Related Experiment Video
Updated: Jul 19, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
Surfactant and its role in chronic sinusitis
1Division of Rhinology and Sinus Surgery, Dept of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, 135 Rutledge Ave, Suite 1130, PO Box 250550, Charleston, SC 29425, USA.
Surfactant, crucial for lower airways, is now found in upper airways, aiding mucus clearance and immunity. This discovery offers new therapeutic avenues for chronic sinus diseases.
Area of Science:
- Respiratory Medicine
- Immunology
- Cell Biology
Background:
- Surfactant's role in lower airways is established, but its function in upper airways remains under-investigated.
- Phospholipids, key surfactant components, are implicated in atrophic rhinitis, suggesting a role in sinonasal health.
- Surfactant proteins (SPs) are vital for innate immunity, with altered levels linked to respiratory diseases.
Purpose of the Study:
- To investigate the presence and role of surfactant phospholipids and proteins in normal and diseased upper airway (sinus) tissue.
- To explore the potential function of sinonasal surfactant in mucociliary clearance, mucus viscosity, and immune defense against pathogens.
Main Methods:
- Demonstration of lamellar body structures (phospholipids) in normal and diseased sinus tissue.
- Analysis of surfactant protein (SP-A and SP-D) expression in sinus tissues.
- Implication of findings based on observed structures and protein expression patterns.
Main Results:
- Lamellar bodies, containing phospholipids, were identified in both normal and diseased sinus tissue.
- Expression of surfactant proteins SP-A and SP-D was demonstrated in sinus tissues.
- These findings suggest sinonasal surfactant secretion and a role in innate immunity and pathogen interaction.
Conclusions:
- Surfactant phospholipids and proteins are present in the upper airways (sinuses) and likely play a role in mucociliary clearance and immune defense.
- Sinonasal surfactant may be secreted by ciliated epithelium and interact early with inhaled pathogens.
- These discoveries open potential therapeutic strategies for chronic and difficult-to-treat sinus diseases.
Related Concept Videos
Breathing
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Respiratory Syncytial Virus Disease
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

